A premix of atrazine, bicyclopyrone, mesotrione, and S-metolachlor has recently been commercialized for pre-emergence (PRE) and early post-emergence (POST) control of broadleaved and annual grass weeds in corn in the United States. Field and greenhouse dose-response bioassays were conducted in 2015 and 2016 to evaluate the response of glyphosate-resistant (GR) horseweed to this premix applied before or after emergence (PRE or POST). In a field PRE study, the 90% effective doses (ED90) were 2613 and 2863 g a.i. ha-1 at 14 and 35 d after treatment (DAT), respectively, which were comparable to the labeled rate (2900 g a.i. ha-1) of the premix. Under greenhouse conditions, POST applications made at the labeled rate to 8–10 or 15–18 cm diameter horseweed rosettes provided ≥97% control. The ED90 values for the in-field POST dose-response study were ≥3431 and ≥6717 g a.i. ha-1 for the 8–10 and 15–18 cm tall GR horseweed, respectively. At 14 DAT, the premix applied at the labeled rate provided 85% and 68% control of 8–10 and 15–18 cm tall GR horseweed, respectively. The root mean square error for the log-logistic model ranged from 4.2 to 9.2 and the model efficiency coefficient values were ≥0.94 (∼ 1.00), indicating a good fit for the prediction model. In conclusion, a new premix applied before emergence (PRE) will effectively control GR horseweed at the labeled rate compared with POST applications made to ≥8 cm tall plants.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.